Treatment with bazedoxifene, a selective estrogen receptor modulator, causes regression of endometriosis in a mouse model

Endocrinology

Volumn 152, Issue 8, 2011, Pages 3226-3232

  Kulak Jr , Jaime ^a,c   Fischer, Catha ^a   Komm, Barry ^b   Taylor, Hugh S ^a  

^a YALE UNIVERSITY   (United States)

^b PFIZER INC   (United States)

^c FEDERAL UNIVERSITY OF PARANÁ   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

BAZEDOXIFENE; CASPASE 3; CYCLINE; ESTROGEN RECEPTOR ALPHA; MESSENGER RNA; TRANSCRIPTION FACTOR HOXA10;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; DRUG EFFICACY; ENDOMETRIOSIS; ENDOMETRIUM; FEMALE; GENE EXPRESSION; HISTOPATHOLOGY; IMMUNOHISTOCHEMISTRY; MOUSE; NONHUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; TREATMENT OUTCOME; UTERUS WEIGHT;

ANIMALS; CASPASE 3; DISEASE MODELS, ANIMAL; ENDOMETRIOSIS; FEMALE; INDOLES; MICE; PROLIFERATING CELL NUCLEAR ANTIGEN; RECEPTORS, ESTROGEN; SELECTIVE ESTROGEN RECEPTOR MODULATORS;

EID: 79960713351     PISSN: 00137227     EISSN: 19457170     Source Type: Journal    
DOI: 10.1210/en.2010-1010     Document Type: Article

References (40)

1. Sarma D, Iyengar P, Marotta TR, terBrugge KG, Gentili F, Halliday W 2004 Cerebellar endometriosis. AJR Am J Roentgenol 182:1543-1546
2. Giudice LC, Kao LC 2004 Endometriosis. Lancet 364:1789-1799 (Pubitemid 39488065)
3. Du H, Taylor HS 2007 Contribution of bone marrow-derived stem cells to endometrium and endometriosis. Stem Cells 25:2082-2086 (Pubitemid 47258186)
4. Gupta S, Goldberg JM, Aziz N, Goldberg E, Krajcir N, Agarwal A 2008 Pathogenic mechanisms in endometriosis-associated infertility. Fertil Steril 90:247-257 (Pubitemid 352040722)
5. Sasson IE, Taylor HS 2008 Stem cells and the pathogenesis of endometriosis. Ann NY Acad Sci 1127:106-115 (Pubitemid 351565719)
6. Seli E, Berkkanoglu M, Arici A 2003 Pathogenesis of endometriosis. Obstet Gynecol Clin North Am 30:41-61 (Pubitemid 36356712)
7. Bischoff F, Simpson JL 2004 Genetic basis of endometriosis. Ann NY Acad Sci 1034:284-299 (Pubitemid 40362368)
8. Taylor HS, Bagot C, Kardana A, Olive D, Arici A 1999 HOX gene expression is altered in the endometrium of women with endometriosis. Hum Reprod 14:1328-1331 (Pubitemid 29224916)
9. Penna I, Du H, Ferriani R, Taylor HS 2008 Calpain5 expression is decreased in endometriosis and regulated by HOXA10 in human endometrial cells. Mol Hum Reprod 14:613-618
10. Penna IA, Hongling Du, Kallen AN, Taylor HS 2010 Endothelin type A receptor (ETA) expression is regulated by HOXA10 in human endometrial stromal cells. Reprod Sci 17:471-476
11. Allen C, Hopewell S, Prentice A, Gregory D 2009 Nonsteroidal anti-inflammatory drugs for pain in women with endometriosis. Cochrane Database Syst Rev 2:CD004753
12. Al Kadri H, Hassan S, Al-Fozan HM, Hajeer A 2009 Hormone therapy for endometriosis and surgical menopause. Cochrane Database Syst Rev 1:CD005997
13. Nawathe A, Patwardhan S, Yates D, Harrison GR, Khan KS 2008 Systematic review of the effects of aromatase inhibitors on pain associated with endometriosis. BJOG 115:818-822 (Pubitemid 351693018)
14. Rodgers AK, Falcone T 2008 Treatment strategies for endometriosis. Expert Opin Pharmacother 9:243-255 (Pubitemid 351233732)
15. Davis L, Kennedy SS, Moore J, Prentice A 2007 Modern combined oral contraceptives for pain associated with endometriosis. Cochrane Database Syst Rev 3:CD001019
16. Hughes E, Brown J, Collins JJ, Farquhar C, Fedorkow DM, Vandekerckhove P 2007 Ovulation suppression for endometriosis. Cochrane Database Syst Rev 3:CD000155
17. Abou-Setta AM, Al-Inany HG, Farquhar CM 2006 Levonorgestrel-releasing intrauterine device (LNG-IUD) for symptomatic endometriosis following surgery. Cochrane Database Syst Rev 4:CD005072
18. Appleyard TL, Mann CH, Khan KS 2006 Guidelines for the management of pelvic pain associated with endometriosis: a systematic appraisal of their quality. BJOG 113:749-757 (Pubitemid 43961733)
19. Allen C, Hopewell S, Prentice A 2005 Non-steroidal anti-inflammatory drugs for pain in women with endometriosis. Cochrane Database Syst Rev 4:CD004753
20. Delmas PD, Bjarnason NH, Mitlak BH, Ravoux AC, Shah AS, Huster WJ, Draper M, Christiansen C 1997 Effects of raloxifene on bone mineral density, serum cholesterol concentrations, and uterine endometrium in postmenopausal women. N Engl J Med 337:1641-1647 (Pubitemid 27510100)
21. Fuchs-Young R, Glasebrook AL, Short LL, Draper MW, Rippy MK, Cole HW, Magee DE, Termine JD, Bryant HU 1995 Raloxifene is a tissue-selective agonist/antagonist that functions through the estrogen receptor. Ann NY Acad Sci 761:355-360
22. Black LJ, Sato M, Rowley ER, Magee DE, Bekele A, Williams DC, Cullinan GJ, Bendele R, Kauffman RF, Bensch WR, et al 1994 Raloxifene (LY139481 HCI) prevents bone loss and reduces serum cholesterol without causing uterine hypertrophy in ovariectomized rats. J Clin Invest 93:63-69 (Pubitemid 24030821)
23. Yao Z, Shen X, Capodanno I, Donnelly M, Fenyk-Melody J, Hausamann J, Nunes C, Strauss J, Vakerich K 2005 Validation of rat endometriosis model by using raloxifene as a positive control for the evaluation of novel SERM compounds. J Invest Surg 18:177-183 (Pubitemid 41200609)
24. Stratton P, Sinaii N, Segars J, Koziol D, Wesley R, Zimmer C, Winkel C, Nieman LK 2008 Return of chronic pelvic pain from endometriosis after raloxifene treatment: a randomized controlled trial. Obstet Gynecol 111:88-96
25. Pinkerton JV, Archer DF, Utian WH, Menegoci JC, Levine AB, Chines AA, Constantine GD 2009 Bazedoxifene effects on the reproductive tract in postmenopausal women at risk for osteoporosis. Menopause 16:1102-1108
26. Archer DF, Pinkerton JV, Utian WH, Menegoci JC, de Villiers TJ, Yuen CK, Levine AB, Chines AA, Constantine GD 2009 Bazedoxifene, a selective estrogen receptor modulator: effects on the endometrium, ovaries, and breast from a randomized controlled trial in osteoporotic postmenopausal women. Menopause 16:1109-1115
27. Kharode Y, Bodine PV, Miller CP, Lyttle CR, Komm BS 2008 The pairing of a selective estrogen receptor modulator, bazedoxifene, with conjugated estrogens as a new paradigm for the treatment of menopausal symptoms and osteoporosis prevention. Endocrinology 149:6084-6091
28. Crabtree JS, Peano BJ, Zhang X, Komm BS, Winneker RC, Harris HA 2008 Activity of three selective estrogen receptor modulators on hormone-dependent responses in the mouse uterus and mammary gland. Mol Cell Endocrinol 287:40-46
29. Peano BJ, Crabtree JS, Komm BS, Winneker RC, Harris HA 2009 Effects of various selective estrogen receptor modulators with or without conjugated estrogens on mouse mammary gland. Endocrinology 150:1897-1903
30. Rackow BW, Taylor HS 2010 Submucosal uterine leiomyomas have a global effect on molecular determinants of endometrial receptivity. Fertil Steril 93:2027-2034
31. Lee B, Du H, Taylor HS 2009 Experimental murine endometriosis induces DNA methylation and altered gene expression in eutopic endometrium. Biol Reprod 80:79-85
32. Taylor HS, Fei X 2005 Emx2 regulates mammalian reproduction by altering endometrial cell proliferation. Mol Endocrinol 19:2839-2846 (Pubitemid 41577253)
33. Prentice A, Deary AJ, Goldbeck-Wood S, Farquhar C, Smith SK 2000 Gonadotrophin-releasing hormone analogues for pain associated with endometriosis. Cochrane Database Syst Rev 2:CD000346
34. Mounsey AL, Wilgus A, Slawson DC 2006 Diagnosis and management of endometriosis. Am Fam Physician 74:594-600
35. Mahutte NG, Arici A 2003 Medical management of endometriosis-associated pain. Obstet Gynecol Clin North Am 30:133-150 (Pubitemid 36356717)
36. Vercellini P, Fedele L, Pietropaolo G, Frontino G, Somigliana E, Crosignani PG 2003 Progestogens for endometriosis: forward to the past. Hum Reprod Update 9:387-396 (Pubitemid 36987285)
37. Schlaff WD, Carson SA, Luciano A, Ross D, Bergqvist A 2006 Subcutaneous injection of depot medroxyprogesterone acetate compared with leuprolide acetate in the treatment of endometriosis-associated pain. Fertil Steril 85:314-325 (Pubitemid 43170902)
38. Winkel CA, Scialli AR 2001 Medical and surgical therapies for pain associated with endometriosis. J Womens Health Gend Based Med 10:137-162 (Pubitemid 32243835)
39. Surrey ES, Hornstein MD 2002 Prolonged GnRH agonist and addback therapy for symptomatic endometriosis: long-term follow-up. Obstet Gynecol 99:709-719 (Pubitemid 34442445)
40. Guo SW, Hummelshoj L, Olive DL, Bulun SE, D'Hooghe TM, Evers JL 2009 A call for more transparency of registered clinical trials on endometriosis. Hum Reprod 24:1247-1254